Anavex Life Sciences Corp.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC AVXL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

668,956

Value ($000)

2,381

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,381	0.0%	668,956	12/31/2025
2025 Q3	11/10/2025	6,385	0.0%	717,378	9/30/2025
2025 Q2	8/12/2025	6,543	0.0%	709,616	6/30/2025
2025 Q1	9/15/2025	5,748	0.0%	669,911	3/31/2025
2024 Q4	2/6/2025	7,273	0.0%	677,215	12/31/2024
2024 Q3	11/12/2024	3,783	0.0%	665,976	9/30/2024
2024 Q2	8/12/2024	2,748	0.0%	651,084	6/30/2024
2024 Q1	5/9/2024	3,207	0.0%	630,067	3/31/2024
2023 Q4	2/6/2024	5,794	0.0%	622,310	12/31/2023
2023 Q3	11/8/2023	3,962	0.0%	604,811	9/30/2023
2023 Q2	8/10/2023	4,726	0.0%	581,262	6/30/2023
2023 Q1	5/12/2023	4,800	0.0%	560,043	3/31/2023
2022 Q4	2/13/2023	5,238	0.0%	565,688	12/31/2022
2022 Q3	11/14/2022	5,603	0.0%	542,859	9/30/2022
2022 Q2	8/15/2022	5,243	0.0%	523,717	6/30/2022
2022 Q1	5/13/2022	6,533	0.0%	530,686	3/31/2022
2021 Q4	2/11/2022	8,945	0.0%	515,840	12/31/2021
2021 Q3	11/16/2021	8,961	0.0%	499,206	9/30/2021
2021 Q2	8/16/2021	3,632	0.0%	158,853	6/30/2021
2021 Q1	5/17/2021	2,223	0.0%	148,639	3/31/2021
2020 Q4	2/16/2021	727	0.0%	134,450	12/31/2020
2020 Q3	11/13/2020	575	0.0%	126,184	9/30/2020
2020 Q2	8/20/2020	621	0.0%	126,184	6/30/2020
2020 Q1	5/15/2020	380	0.0%	120,537	3/31/2020
2019 Q4	2/7/2020	276	0.0%	106,221	12/31/2019